Dr. Amir Kol realized the striking parallels between FIP and severe COVID-19 could offer hope for millions of long COVID ...

And this presents a unique challenge because we don't have any diagnostic tests that we can say, hey, you definitively have long COVID. It really requires a long and extensive and rather expensive ...

For many, COVID-19 has become a distant memory. But for Patricia Hill, it’s an ongoing battle—one that has reshaped her life in ways she never imagined.

While Long COVID presents new challenges, its pathophysiology is not entirely novel. Other infection-associated chronic conditions such as myalgic encephalomyelitis/chronic fatigue syndrome, ...

Everyone who gets a COVID-19 infection is at potential risk for developing long COVID. It’s important to emphasize, especially as we are still living with this virus, that there’s a new risk of ...

When patients feel heard and believed, they become more open to psychological tools—not as a cure, but as a way to cope with uncertainty, identity disruption, and the daily challenges of Long Covid.

Pero is recovering from COVID-19 after a long battle with the virus. ... later on in April he said there were still physical and mental challenges he'd been dealing with during rehab.

Long COVID linked to lasting physical and mental health challenges, study finds—vaccination offers protective benefits. Study: Differences in Long COVID severity by duration of illness, symptom ...

On Sunday, Feb. 16 at 6 p.m., KETV will air its hour-long documentary, "COVID-19: Life After the Pandemic," which highlights everything from the medical communities' memories of the pandemic, to ...

Long COVID destroys teenage lungs in ways doctors never saw - silent damage persists months after mild infections in developing adolescents.

Long COVID, a persistent condition following acute COVID-19 infection, continues to pose challenges for the medical community due to its varied and lasting symptoms. While physical symptoms such ...

Use of donepezil (Aricept), an acetylcholinesterase inhibitor, for 3 weeks failed to demonstrate efficacy in treating fatigue and psychological symptoms of long COVID in a randomized trial from Japan.